Photoplethysmography (PPG) powers QuanBio’s cardiovascular screening platform. This technology uses light sensors to measure blood volume changes within tissues, proving real-time metrics of cardiovascular disease. PPG provides a rapid detection method for the state of the disease by capturing subtle blood flow variations.
Biomarkers are measurable and crucial indicators of cardiovascular health. QuanBio’s technology detects vascular biomarkers using PPG and advanced data processing, tracking changes over time to reveal trends in a person’s cardiovascular health. Aiding clinicians to understand the unique health needs of their patients.
QuanBio’s AI system uses machine learning (ML) and deep learning (DL) to process and interpret vast amounts of health data. ML analyzes historical data to identify trends, such as early signs of coronary and peripheral artery disease. At the same time, DL detects complex interactions between various health metrics.
Arterial stiffness, reflecting artery flexibility, directly impacts cardiovascular health. QuanBio measures arterial stiffness through Pulse Wave Velocity (PWV), assessing the speed of blood pressure waves through the arteries. Higher PWV indicates stiffer arteries, as such providing early warnings for higher risk of cardiovascular events.
QuanBio focuses on early detection to help manage and prevent cardiovascular disease. With the non-invasive device technology, rapid biomarker measurement, and machine learning, QuanBio offers a complete cardiovascular screening and monitoring approach. This approach continuously gathers and analyzes data.
Clinical Validation of AI in Cardiovascular Health
Real-world validation by leading experts in cardiovascular science. Ensuring our AI delivers reliable and impactful health insights
Peripheral Artery Disease (PAD)
Since diabetes contributes to peripheral artery disease by affecting blood vessels, early detection is essential for managing both conditions. By analyzing blood flow patterns and vascular health, QuanBio’s AI identifies high-risk individuals.
Coronary Artery Disease (CAD)
QuanBio’s system detects early signs of arterial blockages and changes in vessel function through cardiovascular data analysis. This AI-driven screening helps identify high-risk individuals before symptoms appear, enabling timely intervention.
Microcirculation
Microcirculation supports tissue health by delivering oxygen and nutrients through the smallest blood vessels. QuanBio’s AI identifies abnormalities in microcirculation using PPG data, flagging potential symptoms early on.
Arterial Aging
QuanBio’s utilizes artificial intelligence to accurately analyze arterial stiffness data and the state of cardiovascular disease. QuanBio’s PPG-based approach provides clinicians with an accessible, non-invasive way to monitor arterial health.
